Vaccination Coverage, Efficacy and Attitude in Targeted Risk Groups

Dear Colleagues,

We are soliciting articles for a Special Issue of MDPI Vaccines, which is entitled “Vaccination coverage, efficacy and attitude in targeted risk groups”.
Vaccination, if available, has proven to be the most effective way of preventing and reducing the burden of many infectious diseases. However, two of the current biggest challenges in the field of vaccinology are the upcoming trend of vaccine hesitancy and the decreased efficacy in risk groups. In fact, if we are able to produce effective and safe vaccines but their uptake is low, the desired effect will not be achieved. Furthermore, vaccines effective in healthy adults could have a decreased effect in the immunocompromised and elderly.
An improved understanding of drivers of vaccine uptake and efficacy will enhance targeted interventions. In addition, due to the high heterogeneity of risk groups in general, one could learn a lot about the efficacy of interventions to increase vaccination uptake and efficacy.
For this Special Issue, risk populations are defined as groups of human individuals with an increased risk of acquiring a (severe) infection because of their behaviour, health, or occupation. These include travellers, immunocompromised patients, and healthcare workers.
We invite perspectives, review articles, and original research articles from specialists in infectious disease education, risk group analysis, vaccination efficacy, vaccination coverage in risk groups, vaccination hesitancy, and clinical and/or preclinical trials.

Dr. Marco Goeijenbier
Prof. Eric C.M. van Gorp
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.